What question did this study set out to answer?

To review current evidence on the efficacy, unique challenges, and long-term benefits of chemotherapy-free dual therapy with all-trans retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia.

January 11, 2021International Journal of Molecular SciencesOpen Access

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

View Full Paper

Ask AI

Bookmark

Authors

CGCarmelo GurnariUniversity of Rome Tor Vergata MVMaria Teresa VosoUniversity of Rome Tor Vergata KGKatia GirardiBambino Gesù Children's Hospital

Discussion

Member takes

Implication

Review reveals high survival with retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia, highlighting the success of chemotherapy-free targeted protocols.

Key Points

To review current evidence on the efficacy, unique challenges, and long-term benefits of chemotherapy-free dual therapy with all-trans retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia.
Narrative review evaluating clinical trial data and literature regarding the translation of adult ATRA and ATO combination regimens to pediatric acute promyelocytic leukemia.
Assessment of pediatric-specific clinical hurdles, focused on induction early death, pseudotumor cerebri, and prevention of long-term organ toxicities.
Dual treatment with ATRA and ATO provides excellent survival outcomes in children, effectively eliminating the need for conventional cytotoxic chemotherapy.
The chemotherapy-free regimen substantially reduces late treatment-related toxicities, though it presents distinct pediatric risks such as pseudotumor cerebri and induction-phase mortality.

Cite This Study

Gurnari et al. (2021) studied this question.

synapsesocial.com/papers/6a0f2e6e14089a5783bdcf7e https://doi.org/10.3390/ijms22020642

View Full Paper

Ask AI

Bookmark

Implication

Review reveals high survival with retinoic acid and arsenic trioxide in pediatric acute promyelocytic leukemia, highlighting the success of chemotherapy-free targeted protocols.

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider